Everio Airmaster

Everio Airmaster is a combination inhaler containing Fluticasone Propionate and Salmeterol Xinafoate, used for managing respiratory conditions. This medication is designed for inhalation use and is manufactured by Zentiva, K.S.

Everio Airmaster is commonly used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). The combination of Fluticasone Propionate, a corticosteroid, and Salmeterol Xinafoate, a long-acting beta-agonist, works to reduce inflammation and relax the muscles in the airways. This can help improve breathing and prevent symptoms such as wheezing, shortness of breath, and coughing. Everio Airmaster is often prescribed for long-term management rather than for immediate relief of symptoms.

When used as directed, Everio Airmaster can help improve lung function and reduce the frequency of asthma or COPD symptoms. Some users may experience common side effects such as throat irritation, hoarseness, or a dry mouth. These effects are generally mild and temporary. It's important to follow the prescribed dosage and administration instructions to minimize potential side effects.

Everio Airmaster should be used under the guidance of a healthcare professional. It is important to rinse your mouth after each use to reduce the risk of throat irritation and fungal infections. Patients with certain medical conditions, such as heart disease or diabetes, should discuss their health status with their healthcare provider before using this medication. Always store the inhaler in a clean, dry place and keep it out of reach of children.

Everio Airmaster may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Additionally, the use of alcohol or other inhalers should be discussed with your healthcare provider to ensure safe and effective use of Everio Airmaster.